Author:
Goss Paul E.,Oza Amit,Goel Rakesh,Nabholtz Jean-Marc,Coster Roland De,Bruynseels Jan,Reid Caroline,Wadden Nancy,Crump Michael,Tye Lesley M.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Beatson GT: On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet 3: 104-107, 1986
2. Henderson IC: Endocrine therapy in metastatic breast cancer. In: Harris JR, Hellman S, Henderson IC, Kinne DW (eds) Breast Diseases. JB Lippincott, Philadelphia, 1987, 421 p
3. Kostraba N, Kiang D, Frenning D, Theologides A, Kennedy BJ: Multiple endocrine therapy in the management of advanced breast cancer. (Abstract #586) Proc Am Assoc Cancer Res 21: 147, 1980
4. Buzdar A, Jonat W, Howell A, Jones SE, Blomqvist C, Vogel CL, Eirmann W, Wolter JM, Azab M, Webster A, Plourde PV for the Arimidex Study Group: Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. J Clin Oncol 14: 2000-2011, 1996
5. Dombernowsky P, Smith I, Falkson G, Leonard R, Panasci L, Bellmunt J, Bezwoda W, Gardin G, Gudgeon A, Morgan M, Fornasiero A, Hoffmann W, Michel J, Harschek T, Tjabbes T, Chaudri HA, Homberger U, Trunet PF: Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. J Clin Oncol 16: 453-461, 1998
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献